Characteristic of Drug Users Chronic Wound

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03608384

Acronym

TOXIPO

Enrollment

Registered

2018-07-31

Start date

2018-08-01

Completion date

2019-02-05

Last updated

2019-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Use, Wound

Brief summary

The aim of this study is to describe demographic, clinical, etiological characteristic and evolution of drug addict's chronic wounds .

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* all drug addict with chronic wound ( evolving at least since 1 month)

Exclusion criteria

* use following medication inductor of cutaneous ulcer: hydroxycarbamide, gefitinib, cetuximab, sunitinib, sorafenib, pazopanib, gemcitabine, sirolimus, methotrexate, nicorandil .

Design outcomes

Primary

Measure	Time frame	Description
clinical venous insufficiency - presence of oedema	at inclusion	presence of oedema

Secondary

Measure	Time frame	Description
clinical venous insufficiency - presence of varicose	at inclusion	presence of varicose
clinical venous insufficiency - presence of white atrophy	at inclusion	presence of white atrophy
clinical venous insufficiency - presence of varicose eczema	at inclusion	presence of varicose eczema

Countries

France

Outcome results